2 results
Approved WMOCompleted
The primary scientific aim of the PROMINENT study is to assess whether treatment with the selective peroxisome proliferator activated receptor modulator alpha (SPPARM-α), pemafibrate, will prevent myocardial infarction (MI), ischemic stroke,…
Approved WMORecruiting
1) To compare gait quality in daily life and challenging gait skills of patients 1 year following cruciate-retaining TKA compared to a healthy, age and gender matched cohort.2) To compare pre- to post-operative cruciate TKA status in quantity and…